1. From the Pediatric Hemato-Oncology Department and the Institute of Hematology, the Chaim Sheba Medical Center, Tel-Hashomer, Tel-Aviv, Israel; Research Center on Pathophysiology of Heamostasis, Catholic University of Medicine, Rome, Italy; Department of Pediatrics, University of California, San Francisco, CA; Department of Medicine, Castrovillari Hospital, Castrovillari, Italy; and Institut for Immunology and Transfusion Medicine, Ernst-Moritz- Arndt-University, Greifswald, Germany.